Xerimis Announces the Debut of Its Purpose-Built, 13,000-Square-Foot United Kingdom Facility

Xerimis announces the debut of its purpose-built, 13,000-square foot United Kingdom facility – the second location for the privately held, New Jersey-headquartered customized clinical packaging provider.

blue-plus Continue Reading
EventNovember 30 – December 1, 2016

Xerimis to exhibit at Clinical Trial Supply-East Asia / Exhibit

This event runs from November 30 – December 1, 2016, in Seoul, Korea. Visit Xerimis at Booth #19.

blue-plus Continue Reading Seoul, Korea

Xerimis Expands Controlled Substances Capabilities

Xerimis Inc. has been approved by the DEA as a registered distributor of schedule 3 through 5 controlled substances.

blue-plus Continue Reading

Carol Sue Bernardo Named Chief Executive Officer of Xerimis Inc.

Xerimis Inc. is proud to announce that Carol Sue Bernardo, Executive Vice President, has been named Chief Executive Officer.

blue-plus Continue Reading